Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT05075564 |
| Title | A Study of ES002023 (Anti-CD39 Antibody) in Patients With Locally Advanced or Metastatic Solid Tumors |
| Recruitment | Unknown status |
| Gender | both |
| Phase | Phase I |
| Variant Requirements | No |
| Sponsors | Elpiscience Biopharma, Ltd. |
| Indications | |
| Therapies | |
| Age Groups: | adult | senior |
| Covered Countries | USA |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| HonorHealth | Scottsdale | Arizona | 85258 | United States | Details | |
| Fayetteville Oncology | Fayetteville | Arkansas | 72703 | United States | Details | |
| UCLA | Los Angeles | California | 90095 | United States | Details | |
| Sarah Cannon Research Institute | Orlando | Florida | 32827 | United States | Details | |
| Cancer Institute of New Jersey | New Brunswick | New Jersey | 08901 | United States | Details | |
| NEXT Austin | Austin | Texas | 78758 | United States | Details | |
| NEXT Virginia | Fairfax | Virginia | 22031 | United States | Details |